LACTB and infection: In general, for infections caused by KPC- or OXA-48-producers, ceftazidime-avibactam (van Duin et al., 2018), or a novel beta-lactam-beta-lactamase inhibitor combination, such as meropenem-vaborbactam, imipenem-cilastain-relebactam (Zhanel et al., 2018), or cefiderocol (Zhanel et al., 2019) are suggested.